vaccine is an injectable emulsion. It is planned for use to prevent salmonellosis in poultry farms of various types, as well as for emergency vaccination in affected and at-risk farms.
The Armavir Biological Factory is listed as the manufacturer of the new drug in the application.
In 2025, veterinary medicine and Life reported on a joint project by CBO Microecology and the Armavir Biofactory to develop and produce vaccines against viral and bacterial infections in poultry and pigs. Production of the drugs was planned to be launched at the biofactory site.
